Oregon · 2025 Regular Session · Bill
HB 2536: Relating to step therapy for metastatic cancer treatment.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 2536 is a bill introduced in the Oregon House on January 13, 2025. According to its official title, it concerns: Relating to step therapy for metastatic cancer treatment. Primary sponsor: Dacia Grayber (Democratic), Kate Lieber (Democratic). It lists 2 additional sponsors. Most recent recorded action (June 28, 2025): In committee upon adjournment.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Prohibits health benefit plans from requiring step therapy prior to covering a prescription drug for the treatment of metastatic cancer and associated conditions.
Sponsors
Sponsors by party (alphabetical): Democratic 4
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Dacia Grayber | Primary sponsor | Democratic | House | 28 |
| Kate Lieber | Primary sponsor | Democratic | Senate | 14 |
| Lew Frederick | Co-sponsor | Democratic | Senate | 22 |
| Cyrus Javadi | Co-sponsor | Democratic | House | 32 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- In committee upon adjournment.
- Public Hearing held.
- Referred to Behavioral Health and Health Care.
- First reading. Referred to Speaker's desk.